Xtant Medical

INVESTORS

HomeInvestors

INVESTORS

Click here for Webcast
Xtant Medical Fourth Quarter 2023 Financial Results
 04/01/24  9:00 AM EDT

Corporate Profile

Xtant Medical Holdings, Inc. (NYSE MKT: XTNT) develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries.

 

 

 

Stock Quote

(Common Stock)
Price
Change (%)
Volume
Data as of  

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Stock Chart

Recent News

Date Title  
Toggle Summary Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million
Establishes Full Year 2024 Revenue Guidance of $112 Million - $116 Million BELGRADE, Mont. , April 01, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported
Toggle Summary Xtant Medical to Issue Fourth Quarter and Full Year 2023 Financial Results on April 1, 2024
BELGRADE, Mont. , March 21, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and
Toggle Summary Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial
BELGRADE, Mont. , March 07, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the Company’s revolving credit agreement with MidCap Financial Trust
Toggle Summary Xtant Medical to Present at the TD Cowen 44th Annual Healthcare Conference
BELGRADE, Mont. , Feb. 26, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne , Chief Executive Officer, will present at the TD Cowen
More
Upcoming Events
There are currently no events scheduled.
More

Receive Email Alerts

Sign up to receive email alerts whenever Xtant Medical Holdings Inc posts new information to the site. Just enter your email address and click Submit.